Content Type: Research Publications

Temporal Trends and Factors Associated with Cardiovascular Drug Development, 1990 to 2012

March 15, 2026

Switch-Backs Associated with Generic Drugs Approved Using Product-Specific Determinations of Therapeutic Equivalence: Generics Approved By Product-Specific Approaches

March 15, 2026

Effect of Generic Competition on Atorvastatin Prescribing and Patients’ Out-Of-Pocket Spending

March 15, 2026

Progress in the Fight Against Multidrug-Resistant Bacteria? A Review of U.S. Food and Drug Administration-Approved Antibiotics, 2010-2015

March 15, 2026

Prescription Drug Insurance Coverage and Patient Health Outcomes: A Systematic Review

March 15, 2026

Key Features of Academic Detailing: Development of an Expert Consensus Using the Delphi Method

March 15, 2026

Development and Use of New Therapeutics for Rare Diseases: Views From Patients, Caregivers, and Advocates

March 15, 2026

Are Risk Evaluation and Mitigation Strategies Associated with Less Off-Label Use of Medications? The Case of Immune Thrombocytopenia

March 15, 2026

A Cross‐National Comparison of 17 Countries’ Insulin Glargine Drug Labels

March 15, 2026

Mandatory Disclaimers on Dietary Supplements Do Not Reliably Communicate the Intended Issues

March 15, 2026

Availability and Utilization of Cardiovascular Fixed-Dose Combination Drugs in the United States

March 15, 2026

Hatch-Waxman Turns 30: Do We Need a Re-Designed Approach for the Modern Era?

March 15, 2026